The 2 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +135.76% increase from the last price of 2.55.
The current consensus among 4 polled investment analysts is to Hold stock in Emergent BioSolutions Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.67
Reporting Date Feb 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.